With health care reform initiatives, quality measurement, and requirements for much greater accountability to numerous stakeholder groups, new questions arise constantly that need to be answered with more depth and greater insight. 

Healthcare companies operate in an industry having truly unique challenges like long product development life cycles, regulated environments of different countries, complex market dynamics, etc. Our reports help these organizations to make informed business decisions in this increasingly challenging business environment.

We specialize in high-level information processing and analysis, specific to the needs of Healthcare and related industries worldwide. These reports contain analytical as well as statistical information on Healthcare industry. We thoroughly analyze new vistas being opened by the strongly growing healthcare industry like Telemedicine, Healthcare IT, Medical Devices, Medical Tourism, Health Insurance, E Health and Hospital Services.

China Healthcare Market Forecast to 2015 May, 2012  |  Pages : 135 Chinese healthcare expenditure is projected to increase at a CAGR of around 19% during 2012-2015 backed by increasing aging population, and continuously growing prevalence of lifestyle diseases... read more Buy Now US$ 1000.00 EPO Biosimilars Market Forecast to 2015 May, 2012  |  Pages : 34 EPO biosimilars market is anticipated to reach US$ 275 Million by the end of 2015 driven by patent expirations of key epoietin drugs, such as Epogen and Procrit... read more Buy Now US$ 300.00 G-CSF Biosimilars Market Forecast to 2015 May, 2012  |  Pages : 35 It is expected that the patent expiries of Neupogen and Neulasta (pegfilgrastim) will make the way for the entry of G-CSF biosimilars which are anticipated to touch the US$ 350 Million-mark by 2015... read more Buy Now US$ 300.00 Global API Market Analysis May, 2012  |  Pages : 85 Supported by factors, such as emergence of India and China as prominent API manufacturing hub, and patent expiration etc, Global API market is likely to register CAGR of around 8% during 2012-2015... read more Buy Now US$ 1200.00 HGH Biosimilars Market Forecast to 2015 May, 2012  |  Pages : 35 The global HGH biosimilars market is expected to be worth around US$ 125 Million by 2015-end though the development for new HGH biosimilars has been slow... read more Buy Now US$ 300.00 Infectious Disease Molecular Diagnostics Outlook 2015 May, 2012  |  Pages : 85 Dominated by HIV and CT/NG testing, the infectious disease market is anticipated to grow at the CAGR of around 11% during the forecast period, 2012-2015... read more Buy Now US$ 1400.00 US Nutraceuticals Market Analysis May, 2012  |  Pages : 105 Nutraceutical products are expected to receive tremendous public and private sector attention in the years to come that will enable the industry to grow at a CAGR of around 7% during 2012-2015... read more Buy Now US$ 1000.00 Global Gene Therapy Market Analysis Apr, 2012  |  Pages : 120 Global gene therapy market is anticipated to attain exceptional growth with the advent of new drugs in the market and reach to a stupendous mark of US$ 325 Million by 2015-end... read more Buy Now US$ 1200.00 Global Protein Therapeutics Market Forecast to 2015 Apr, 2012  |  Pages : 160 Protein therapeutics market is likely to reach the mark of US$ 143.4 Billion by 2015-end, with the entry of new products, especially monoclonal antibodies in the market... read more Buy Now US$ 1800.00 Global RNAi Market Analysis Apr, 2012  |  Pages : 105 Propelled by the rising usage of the RNAi technology as a research tool in functional genomics, global RNAi market is anticipated to grow stupendously at a CAGR of around 17% during 2011-2015... read more Buy Now US$ 1200.00

Pages:    1  2   3   4   5   6   7   8   9   10   Next   Page  1 of 10